Low-Risk Myelodysplastic Neoplasm (MDS): Time for a Name Change?

January 2025 in “ HemaSphere ”

Shoshana Burke, Stephen Hibbs

Studysummary This review discusses the implications of renaming myelodysplastic syndromes as "myelodysplastic neoplasms" and argues that the "low-risk" label may misrepresent patient experiences and hinder research.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community Why don’t people just just DUT instead of FIN?

in Finasteride/Dutasteride 48 upvotes 2 years ago

The conversation discusses the use of dutasteride (DUT) versus finasteride (FIN) for hair loss treatment, with some users preferring DUT for its effectiveness while others choose FIN due to its approval status, better long-term data, and lower risk of side effects. Users share personal experiences with both medications, including side effects and effectiveness.

community Don’t let them scare you from finasteride. 8 months

in Progress Pictures 270 upvotes 2 years ago

A user shared their 8-month progress using 1mg oral finasteride with no side effects and plans to start minoxidil. Another user commented that the results look great and suggested reconsidering starting minoxidil.

community Mesotherapy & Low level laser out therapy update . Oral Fin ,Topical Min, Dut, Hair Fibers

in Is this regrowth? 1 upvotes 1 year ago

The user is undergoing Mesotherapy and Low-Level Laser Therapy for hair loss, with plans for multiple sessions. They are also using oral finasteride, topical minoxidil, dutasteride, and hair fibers.

community Community ranking on what new drugs/studies we are most hopeful about?

10 upvotes 2 months ago

The conversation discusses potential hair loss treatments, including clascoterone, GT20029, ET-02, VDPHL01, and PP405, with hopes for new options by 2028. Current treatments like minoxidil and finasteride are expected to remain effective, with clascoterone and VDPHL01 as promising alternatives.

community Why do some doctors recommend starting with minoxidil before finasteride? (treatment philosophy question)

in Research/Science 20 upvotes 5 months ago

Doctors recommend starting with minoxidil for hair loss due to its lower risk of side effects compared to finasteride. Some believe finasteride should be used early to address the root cause, but a conservative approach is preferred by medical professionals.

community One year of Min + Fin to salvage a chance at a transplant

in Progress Pictures 26 upvotes 8 months ago

The user has been using 1MG finasteride, 5% minoxidil, LLLT, and derma stamping for a year to improve hair density for a potential transplant. They are considering switching to dutasteride and are unsure whether to proceed with a transplant now or wait for more growth.

Similar Research

5 / 1000+ results

research Identification of a Novel MPL Loss of Function Mutation in a Patient with Cyclic Thrombocytopenia and Characterization of This Syndrome

4 citations , December 2016 in “Blood”

This study describes a case of cyclic thrombocytopenia where a novel MPL gene mutation may contribute to the disease, with gene expression changes in platelet and neutrophil genes preceding platelet count fluctuations.

research [Commentary] The Polyfollicular Anovulatory Androgenic Syndrome: A New Label for an Old Syndrome

December 2022

This article discusses the issues with the name "polycystic ovary syndrome" and proposes a new naming system to better reflect the condition's complex hormonal and metabolic abnormalities.

Philological Obfuscation: Observations on Medical Categorization and Labeling

research Philological Obfuscation

May 2009 in “South African Family Practice”

The author believes that giving medical conditions official names can sometimes overwhelm or scare patients.

research Minoxidil ameliorates myelodysplastic syndrome by targeting Wnt4 while sparing normal hematopoiesis

December 2025 in “Cell Communication and Signaling”

This study discovered that minoxidil affects hematopoiesis by downregulating wnt4, leading to suppression of hematopoietic stem and progenitor cells and alleviating MDS-like symptoms in zebrafish and mice, with hematologic safety achieved at optimized doses.

research Non‐myeloablative stem cell transplants

22 citations , October 2000 in “British Journal of Haematology”

This article discusses the development of non-myeloablative stem cell transplants, which may expand the safe treatment range of allogeneic SCT, but presents no new clinical results.